文献速递瓣膜外科

三尖瓣置换术的瓣膜选择:临床与超声心动图结局比较

Prosthesis choice for tricuspid valve replacement: Comparison of clinical and echocardiographic outcomes.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-07-08

本研究回顾1043例首次三尖瓣置换术成人患者,机械瓣149例(14%)、生物瓣894例(86%)。生物瓣与机械瓣在生存率和再手术累积发生率方面相似,右心室功能与扩张在术后改善,但生物瓣晚期中重度以上三尖瓣反流复发率更高。

要点

  • 生物瓣与机械瓣置换术后生存率和再手术累积发生率相似。
  • 术后右心室功能与扩张改善,3年随访时中重度以上右心室收缩功能障碍或扩张的估计比例下降约20%。
  • 生物瓣置换与晚期随访中更高的中重度以上三尖瓣反流复发率相关。

核心结论

  • 机械瓣与生物瓣在三尖瓣置换术后提供相当的生存率、再手术发生率和右心室收缩功能与大小的恢复。
  • 生物瓣随时间推移出现显著三尖瓣反流,机械瓣可能对年轻患者和需要抗凝的患者有优势。

研究设计与样本

  • 回顾性分析1043例连续成人首次三尖瓣置换术患者,其中33%既往有主动脉瓣和/或二尖瓣手术。
  • 94%患者手术指征为重度三尖瓣反流,机械瓣用于149例(14%),生物瓣用于894例(86%)。
  • 57%患者同期行主要心脏手术。

主要发现

  • 队列中位年龄68.8岁(范围25-94岁),女性占57%。
  • 总体5年和10年生存率分别为50%和31%。
  • 调整后,生物瓣与机械瓣患者的生存率和再手术累积发生率相似。
  • 术后右心室功能和扩张改善,3年随访时中重度以上右心室收缩功能障碍或扩张的估计比例下降约20%。
  • 调整术前功能障碍或扩张程度后,瓣膜类型对右心室功能和扩张的晚期改善无影响。

临床怎么用

  • 作者认为机械瓣可能对年轻患者和需要抗凝的患者有优势。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There is limited evidence evaluating valve function and right heart remodeling after tricuspid valve replacement (TVR), as well as whether the choice of prosthesis has an impact on these outcomes. METHODS: We reviewed 1043 consecutive adult patients who underwent first-time TVR; 33% had previous aortic and/or mitral valve operations. Severe tricuspid valve regurgitation (TR) was the indication for surgery in 94% patients. A mechanical valve was used in 149 (14%) patients and a bioprosthetic valve in 894 (86%). Concomitant major cardiac procedures were performed in 57% of patients. RESULTS: The median age of the cohort was 68.8 (range, 25-94) years, and 57% were female. Overall survival at 5 and 10 years was 50% and 31%, respectively. Adjusted survival and cumulative incidence of reoperation after TVR were similar in patients with bioprosthetic and mechanical valves. Overall, right ventricular (RV) function and dilation improved postoperatively with the estimated proportion of patients with moderate or greater RV systolic dysfunction/dilatation decreasing by around 20% at 3 years follow-up. After adjusting for preoperative degree of dysfunction/dilatation, valve type had no effect on late improvement in RV function and dilation. Bioprosthetic TVR was associated with greater rates of recurrence of moderate or greater TR over late follow-up. Overall, a slight decline in tricuspid valve gradients was observed over time. CONCLUSIONS: Mechanical and bioprosthetic valves provide comparable survival, incidence of reoperation, and recovery of RV systolic function and size after TVR. Bioprosthetic valves develop significant TR over time, and mechanical valves may have an advantage for younger patients and those needing anticoagulation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Patlolla SH, Saran N, Schaff HV, et al. Prosthesis choice for tricuspid valve replacement: Comparison of clinical and echocardiographic outcomes. J Thorac Cardiovasc Surg. 2022. PMID: 36028365. doi:10.1016/j.jtcvs.2022.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。